"DXB and MSB haven't got the history of slams like us too"
MSB has a history of FDA rejections.
The recent price hike is because of MASSIVE insider buying on the market this month.
DXB is a long way from approval but partnerships give an independent stamp of confidence (and cash).
Nina is a good negotiator.
For BOT it seems clear that someone is working hard to cap us at 30c.
BOT - Anything but charting, page-8565
-
- There are more pages in this discussion • 3,092 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.8¢ |
Change
-0.003(0.74%) |
Mkt cap ! $617.9M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 33.8¢ | 33.5¢ | $46.10K | 137.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 340875 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 98600 | 5 |
View Market Depth
| Last trade - 10.00am 11/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |